The effect of cinnarizine and cocculus indicus on simulator sickness

Physiology and Behavior

Volumn 91, Issue 1, 2007, Pages 180-190

  Lucertini, Marco ^a   Mirante, Nadia ^a,b   Casagrande, Maria ^a,b   Trivelloni, Pierandrea ^a   Lugli, Vittoria ^a  

^a Volo Reparto Medicina Aeronautica e Spaziale   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cinnarizine; Cocculus indicus; Motion sickness; Postural balance; Simulator sickness; Sleepiness

Indexed keywords

CINNARIZINE; COCCULUS INDICUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COCCULUS; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; MALE; MOTION SICKNESS; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SOMNOLENCE; VISUAL ANALOG SCALE;

EID: 34247195501     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.02.008     Document Type: Article

References (55)

1. Kolasinski E.M. Simulator Sickness in Virtual Environments (1995). http://eserver.org/cyber/simsick.html http://eserver.org/cyber/simsick.html
2. Kennedy R.S., Hettinger M.G., and Lilienthal. Simulator sickness. In: Crampton G.H. (Ed). Motion and space sickness (1990) Chapter 15
3. Kennedy R.S., Berbaum K.S., and Lilienthal M.G. Disorientation and postural ataxia following flight simulation. Aviat Space Environ Med 68 (1997) 13-17
4. Gillingham R., and Previc J. Spatial orientation in flight. Armstrong Laboratory (1993)
5. Crosby T.N., and Kennedy R.S. Postural Disequilibrium and Simulator Sickness Following Flights in a P3C Operational Flight Trainer. Paper presented at the 53rd Ann. (1982), Aerospace Med. Assoc., Bal Harbor, FL May
6. Fowlkes J.E., Kennedy R.S., and Lilienthal M.G. Postural disequilibrium following training flights. Proc. 31st Ann. Hum. Factors Soc (1987), Human Factors Society, Santa Monica, CA 488
7. Kennedy R.S., Fowlkes J.E., and Lilienthal M.G. Postural and performance changes following exposures to flight simulators. Aviat Space Environ Med 64 (1993) 912-920
8. Hamilton K.M., Kantor L., and Magee L.E. Limitation of postural equilibrium tests for examining simulator sickness. Aviat Space Environ Med 60 (1989) 246-251
9. Barnum F., and Bonner R.H. Epidemiology of USAF spatial disorientation aircraft accidents, 1 Jan 1958 - 31 Dec 1968. Aeros Med 42 (1971) 896-898
10. Ungs T.J. Simulator induced syndrome: evidence for long-term aftereffects. Aviat Space Environ Med 60 (1989) 252-255
11. Malmstrom F. Simulator sickness. Fly Saf (June 22-24, 1991)
12. Kennedy R.S., Lilienthal M.G., Berbaum K.S., Baltzley D.R., and McCauley M.E. Simulator sickness in U.S. Navy flight simulators. Aviat Space Environ Med 60 (1989) 10-16
13. Wood C.D., Manno J.E., Manno B.R., Redetzki H.M., Wood M.J., and Mims M.E. Evaluation of Antimotion Sickness Drug Side Effects on Performance. Aviat Space and Env Med 56 (1985) 310-316
14. Gordon C.R., Gonen A., Nachum Z., Dowech I., Spitzer O., and Shupak A. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J Psychopharmacol 15 3 (2001) 167-172
15. Nicholson A.N., Stone B.M., Turner C., and Mills S.L. Central effects of cinnarizine: restricted use in aircrew. Aviat Space Environ Med 73 (2002) 570-574
16. Macnair A.L. Cinnarizine in the prophylaxis of car sickness in children. Curr Med Res Opin 8 (1983) 451-455
17. Oosterveld W.J. The Combined Effect of Cinnarizine and Domperidone on Vestibular Susceptibility. Aviat Space Environ Med 58 (1987) 218-223
18. Wood C.D. Pharmacological countermeasures against motion sickness. In: Crampton G.H. (Ed). Motion and Space Sickness (1990), CRC Press, Boca Raton 344
19. Pingree B.J.W., and Pethybridge R.J. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness. Aviat Space Environ Med 65 (1994) 597-605
20. Doweck I., Gordon C.R., Spitzer O., Melamed Y., and Shupak A. Effect of cinnarizine in the prevention of seasickness. Aviat Space Environ Med 65 (1994) 606-609
21. Van Neuten J.M., and Jensen P.A. Comparative study on the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues. Arch Int Pharmacodyn 37 (1973) 204
22. Emanuel M.B. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 30 (1979) 454-469
23. Shupak A., Doweck I., Gordon C.R., and Spitzer O. Cinnarizine in the prophylaxis of seasickness: Laboratory vestibular evaluation and sea study. Clin Pharmacol Ther 55 (1994) 670-680
24. Gordon C.R., and Shupak A. Prevention and treatment of motion sickness in children. CNS Drugs 12 (1999) 369-381
25. Pingree B.J.W., and Pethybridge R.J. A double-blind placebo-controlled comparison of hyoscine with early administered cinnarizine in increasing tolerance to a nauseogenic cross-coupled motion challenge. Pharm Med 4 (1989) 29-42
26. Dobie T.G., and May J.G. Cognitive Behavioral management of motion sickness. Aviat Space Environ Med 65 10, Suppl. (1994) C1-C20
27. Towse G. Cinnarizine - a labyrinthine sedative. J Laryngol Otol 94 (1980) 1009-1015
28. Hargreaves J. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness. Practitioner 224 (1980) 547-550
29. Lee J.A., Watson L.A., and Boothby G. Calcium antagonists in the prevention of motion sickness. Aviat Space Environ Med 57 (1986) 45-48
30. Morrison P.J., Bradbrook I.D., and Rogers H.J. Plasma cinnarizine levels resulting from oral administration as capsule or tablet formulation investigated by gas-liquid chromatography. Br J Clin Pharmacol 7 (1979) 349-352
31. Parrot A.C., and Wesner K. Prometazine, scopolamine and cinnarizine: comparative time-course of psychological performance effects. Psychopharmacol 92 (1987) 513-519
32. Smith T. Homeopathic Medicine (1982), Thorsons Publishers Ltd.
33. Hahnemann S. Organon dell'arte del guarire. Ed. S.I.M.O.H. Roma 1993.
34. Linde K., Clausius N., Ramirez G., Melchart D., Eitel F., Hedges L.V., and Jonas W.B. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 350 (1997) 834-843
35. The Homeopathic Pharmacopoeia of the United States (HPUS). eighth ed (1979), Falls Church, VA
36. Klopp R., Niemer W., and Weiser M. Microcirculatory effects of a homeopathic preparation in patients with mild vertigo: an intravital microscopic study. Microvasc Res 69 (2005) 10-16
37. Lucertini M., and Lugli V. The Italian Air Force rehabilitation program for air-sickness. Acta Otorhinolaryngol Ital 24 4 (Aug. 2004) 181-187
38. Kennedy R.S., Lane N.E., Berbaum K.S., and Lilienthal M.G. Simulator sickness Questionnaire: An Enhanced Method for Quantifying simulator Sickness. The Intern J Aviat Psych 3 3 (1993) 203-220
39. Kellogg R.S., Kennedy R.S., and Graybiel A. Motion sickness symptomatology of labyrinthine defective and normal subjects during zero gravity maneuvers. Aeros Med 36 (1965) 315-318
40. Casagrande M., Curcio G., Ferrara M., Tricarico M., Urbani L., and Porcù S. Subjective ratings of sleepiness: sensitivity of different measures in revealing time of day effects. Sleep Res Online 2 Sup.1 (1999) 226
41. Gillberg M., Kecklund G., and Åkerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep 17 (1994) 236-241
42. Kellogg R.S., Castore C.H., and Coward R.E. Psychophysiological Effects of Training in a Full Vision Simulator. Paper presented to the Aerospace Medical Association (1980), Anaheim, CA May 1 to 4
43. Casali J.G. Vehicular Simulation-Induced Sickness. Vol. I. An Overview. NTSC-TR-010 (1986), Naval Training System Center, Orlando, FL
44. Hettinger L.J., Berbaum K.S., Kennedy R.S., Dunlap W.P., and Nolan M.D. Vection and simulator sickness. Mil Psychol 2 3 (1990) 171-181
45. Baltzley D.R., Kennedy R.S., Berbaum K.S., Lilienthal M.G., and Gower D.W. The time course of post-flight SS symptoms. Aviat Space Environ Med 60 (1989) 1043-1048
46. Hettinger L.J., Nolan M.D., Kennedy R.S., Berbaum K.S., Schnitzius K.P., and Dinger K.M. Visual display factors contributing to simulator sickness. Proc. Hum. Factors Soc (1987), Human Society, Santa Monica, CA 497
47. McGuiness J., Bouwman J.H., and Forbes J.M. Simulator Sickness Occurrences in the 2E6 Air Combat Maneuvering Simulator (ACMS). Tech, Rep. No. NAVTRAEQUIPCEN 80-C-0315-4500-1 (1981), Naval Training Equipment Center, Orlando, FL
48. Nuti D, Biagini C. Eziopatogenesi e Trattamento della Cinetosi. Otoneurologia 2000 maggio, 3, 2000.
49. Hartman B.O., and Hatsell C. Field Study: SAAC Simulator. USAF School of Aerospace Medicine, Brooks Air Force Base, TX (1976) October
50. Havron M.D., and Butler L.F. Evaluation of Training Effectiveness of the 2FH2 Helicopter Flight Trainer Research Tool. Tech. Rep. No. NAVTRADEVCEN 1915-00-1 (1957), Naval Device Center, Port Washington, NY
51. Cullen J.R., Hall S.J., and Allen R.H. Effect of betehistine dihydrochloride compared with cinnarizine on induced vestibular nystagmus. Clin Otolaryngol Allied Sci 14 (1989) 485-487
52. Oosterveld W.J. A comparative study of the effects of cinnarizine, sulpiride and thiethylperazine on vestibular nystagmus in rabbits. Eur J Pharmacol 50 (1978) 91-96
53. Mangabeira-Albernaz P.L., Gananca M.M., Novo N.F., and De Paiva E.R. Flunarizine and cinnarizine as vestibular depressants. A statistical study. ORL 40 (1978) 92-100
54. Nordahl S.H., Aasen T., Dyrkorn B.M., Eidsvik S., and Molvaer O.I. Static stabilometry and repeated testing in a normal population. Aviat Space Environ Med 71 (2000) 889-893
55. Kleijnen J., Knipschild P., and Ter Riet G. Clinical trials of homoeopathy. BMJ 302 (1991) 316-323